Apollo Clinic secures NABH certification for the second time for its clinics in Karnataka: Our Bureau, Bengaluru Wednesday, ...

NLS Pharma & Kadimastem enter into definitive merger agreement: Zurich, Switzerland Wednesday, November 6, 2024, 12:00 Hrs [IST] NLS Pharmaceutics Ltd. (NLS), a biopharmaceutical ...

Memo Therapeutics AG (MTx), a late-stage biotech company translating unique immune responses into superior medicines to treat ...

The UK government will create the world’s first real-time surveillance system to monitor the threat of future pandemics, prevent disease, and protect the public. Plans have been announced to form a ...

StarFish Medical expands local footprint to California by acquiring Omnica Corporation: Toronto, Canada Wednesday, November 6, 2024, 09:00 Hrs [IST] StarFish Medical, a leading No ...

Indian pharma, medical practitioners & medical academia work to reduce burden of NCDs: Dr Sunil Chiplunkar: Nandita Vijayasimha, Bengaluru Wednesday, November 6, 2024, 08:00 Hrs [ ...

Even as the government of Tamil Nadu is taking all steps to launch the subsidized generic pharmacy network scheme, ‘Mudhalvar Marundhagam’ (Chief Minister’s Pharmacy) on the day of Tamil New Year ...

DBT soon to begin research on consequences of viral infection on cardiovascular health & prevention strategies: Gireesh Babu, New Delhi Wednesday, November 6, 2024, 08:00 Hrs [IST ...

ICMR launches 'First in the World Challenge' to revolutionize biomedical science: Shardul Nautiyal, Mumbai Wednesday, November 6, 2024, 08:00 Hrs [IST] In a move inspired by India ...

The Directorate General of Foreign Trade (DGFT) has introduced modifications to the Standard Input Output Norm (SION) E-125, covering exports of Shea Stearine, under Paragraph 1.03 of the Foreign ...

The Union government has recently released the new BioE3 (Biotechnology for Economy, Environment and Employment) policy for fostering high performance biomanufacturing which is the ability to produce ...

Novo Nordisk, a leading global healthcare company, announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, double-blinded trial in 1,200 adults with ...